That is more than three times higher than last year, but not quite at the same level that was reached in the 2022-2023 flu season, according to the UK Health Security Agency (UKHSA), which has called ...
Alex Brenchat, PhD, is VP and practice area lead for local pharmacovigilance services at PharmaLex. Brenchat has more than 20 ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...
Every new drug entering clinical trials requires careful decision-making, particularly regarding trial design and resource ...
In a new report, ‘Helping others: unlocking the potential of ‘other’ cancers through predictive analytics’, the Concr team – co-founders Matthew Foster and Matthew Griffiths, together ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.
Recruiting for clinical trials is hard… and expensive. And a large component of that time involves people sifting through medical data, by hand, to see if someone qualifies for a study or not.
Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related breathing disorder that is most common in people who are overweight and ...
Sensorion's gene therapy for otoferlin-related hearing loss – a congenital form of deafness – has shown early signs of improving hearing in two toddlers treated in a phase 1/2 trial.
Incorporating environmentally friendly practices has become everyone's responsibility. In recent years, policymakers and organisations have particularly intensified sustainability practices among ...
The money spent by the NHS on newly approved therapies recommended by NICE might have been better spent elsewhere, according to a new study. The paper – published in The Lancet - revolves around ...
Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker Essential Pharma that will provide funds to expand its product ...